ArticlePLoS medicine2016

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study.

Christine A Parkinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.